Friday, October 16, 2020
12:26 PM EST – Softlab9 Technologies Inc. : Announced that it has placed its first order of COVID-19 testing kits from Zhejiang Orient Gene Biotech Co. Ltd. SOFT has purchased 1000 Rapid Antigen Test Kits from Zhejiang. This first purchase order will be used to distribute samples to potential clients. SOFT has been pursuing governmental agencies, hospitals, and end users to distribute its new line of personal protective equipment and testing products. The RA Test Kits are FDA approved in the United States, Therapeutic Goods Administration (TGA) approved in Australia and CE approved in Europe, but not Health Canada approved. The Company, however, does have approval from Zhejiang to sell the RA Test Kits in jurisdictions around the world where they are approved for usage. Rahim Mohamed, CEO of SOFT said, “We continue to look for opportunities in the health sector, from sanitization to personal protective equipment, and now, testing kits for the current pandemic. These products are increasingly difficult to source, and we are committed to providing our clients with a steady supply and one-stop-shop for their needs.” Softlab9 Technologies Inc. (C.SOFT) shares were up 6 cents at 0.77.
Stocks in Play: Softlab9 Technologies Inc., Fri, 16 Oct 2020 12:30:04 EST